VA to Fund First Psychedelic Therapy Study for Veterans Since 1960s

December 6, 2024

Lykos, FDA Discuss Phase 3 MDMA Trial Plans

October 20, 2024

Experts Urge Further Study on Psychotherapy’s Influence on MDMA Therapy

October 4, 2024

Lykos Therapeutics Shakeup Continues With Leadership Change

September 6, 2024

Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection

August 22, 2024

MDMA for PTSD: Setback Sparks New Battle Plan

August 14, 2024